2011 - PhD Immunology, Cardiff University School of Medicine
2006 - MS Biochemistry, University of Oxford
Academic Background
Dr Lissina has 15 years of experience in the field of immunology. After obtaining an MSc in Biochemistry from the University of Oxford, she studied for a PhD in infection and immunity at Cardiff University School of Medicine, investigating the different means of improving the interaction between the T-cell receptor (TCR; the molecule central to T-cell specificity and function) and its target, the peptide-MHC, for diagnostic and therapeutic applications. In 2011, she relocated to Paris to take up a post-doctoral position at the Pierre and Marie Curie University (UPMC) in the HIV pathogenesis and immunosenescence group with the aim of optimizing vaccination efficacy. During this time, she also worked alongside collaborators at the Vaccine Research Center (NIH, Bethesda, MA, USA) and the Centre for AIDS Research (Kumamoto, Japan). Her final post-doctoral role at the Department of Cellular and Molecular Medicine at the University of Bristol involved investigating the causes of CD8+ T-cell large granular lymphocytic leukemia. Most recently, she managed a large NIHR-funded research program investigating the benefits of early screening for psoriatic arthritis at the University of Bath.
Publishing History
Dr Lissina has authored 30 peer-reviewed papers, nine as first author, in journals such as Nature Medicine, Aging Cell, Immunology, Journal of Immunology, and AIDS.
Editing and Reviewing Experience
Dr Lissina has edited technical/scientific manuscripts for colleagues and several medical communications platforms as a freelance editor. She has also peer reviewed papers submitted to the Journal of Virology, the European Journal of Immunology, and Plos Pathogens. Dr Lissina joined Edanz as an editor in 2022.
Writing Experience
Dr Lissina has co-written a book chapter for the Encyclopedia of AIDS (published in 2014, Springer), and has experience in preparation of REF impact case studies, technical reports, grant applications, and patient newsletters.
